Viral exanthems
Characteristic rash
Measles (Rubeola)
 A RNA virus causing acute febrile eruption
 Found only in humans
 Transmission by nasopharyngeal secretions
 Highly contagious, with ~90% secondary
attack rate
 Virus grows in respiratory epithelium &
spreads by blood
 Incubation period- ~10 days
Clinical features
 Initially high-grade fever, malaise, dry
cough, nasal discharge
 Erythematous maculopapular rash after ~1
week
 Koplik’s spots on oral mucosa
 Rash starts from forehead, and spreads downwards
 Resolution in same order over 3 days
 Complications-
 Viral or secondary bacterial pneumonia
 Myocarditis, hepatitis, keratitis
 Encephalomyelitis
 Subacute sclerosing pan-encephalitis (SSPE)- rare, late
Management
 Dx-
 Clinical
 Leukopenia
 Measles virus/Ag in respiratory secretions/urine
 Treatment- supportive
 Prevention-
 Passive immunization with immunoglobulin
 Active immunization with vaccine
Varicella-zoster
 A DNA virus
 Man is only reservoir
 Transmission- respiratory secretions-?
 Highly contagious, >90% secondary attack
rate
 Incubation period- ~2 weeks
 Causes-
 Varicella/chicken-pox- primary infection- children
 Zoster- reactivation- elderly/immunocompromised
Clinical features
 Varicella- lasts ~7 days
 Fever, malaise
 Rash- erythematous macules, papules, vesicles, scabs
in various stages of evolution simultaneously
 First on face & trunk, then spreads
 Complication- secondary bacterial infection, pneumonia,
hepatitis, ataxia, meningitis, myelitis
 Herpes zoster- lasts ~7 days
 Reactivation of virus from dorsal root ganglia
 U/L dermatomal severe pain, followed by vesicular eruption
 Complication- post-herpetic neuralgia, meningoencephalitis
Management
 Dx-
 Clinical
 Tzanck smear- multinucleated giant-cell
 Isolation of virus in tissue culture
 Rising Ab titres
 Rx-
 Supportive
 Acyclovir- oral/IV
 Steroids & neuropathic analgesics for neuralgia
 Prevention-
 Passive immunoglobulins
 Active vaccine
Herpes simplex
 A ds-DNA virus
 HSV-1- oral, HSV-2- genital
 Transmission- by direct contact,
genital herpes considered a STD
 Incubation period- ~1 week
 Initial exposure- local viral replication
 Through peripheral nerves, virus reaches ganglia
 Replicates in ganglia & spreads centrifugally to skin via
peripheral sensory nerves
 Reactivation- with stress, trauma, immunosuppression
Clinical features
 Initial disease more symptomatic than
recurrences
 Fever, malaise, myalgia; with painful
vesicular eruption & regional LNE
 Herpes labialis/orofacial/gingivostomatitis
 Herpes genitalis
 Herpetic whitlow- fingers
 Herpetic keratoconjunctivitis
 Herpes encephalitis
Management
 Dx-
 Clinical
 DFA
 Biopsy
 IgG HSV test
 Rx- topical/oral Acyclovir; reduce frequency,
duration, severity; NOT CURATIVE
 Prevention-
 Barrier- condom
 Prophylactic Acyclovir
Rubella- German measles
 Caused by Rubella virus (RNA)
 Incubation period- ~2-3 weeks
 A benign febrile viral disease with LNE
 Rash- discrete maculopapular rash,
starts on forehead & face and spread down
 Rash typically lasts for ~3 days
 Prevention- live attenuated vaccine,
specially to prevent congenital rubella
Congenital rubella
 Consists of-
 Cardiac malformation- PDA, VSD, PS
 Eye lesions- clouded cornea, cataract, chorioretinitis
 Microcephaly
 Mental retardation
 Deafness
 Expanded rubella syndrome-
 Purpura, HSmegaly, IUGR, pneumonitis, myocarditis
 Late complications-
 DM, subacute panencephalitis

Viral exanthems

  • 1.
  • 2.
    Measles (Rubeola)  ARNA virus causing acute febrile eruption  Found only in humans  Transmission by nasopharyngeal secretions  Highly contagious, with ~90% secondary attack rate  Virus grows in respiratory epithelium & spreads by blood  Incubation period- ~10 days
  • 3.
    Clinical features  Initiallyhigh-grade fever, malaise, dry cough, nasal discharge  Erythematous maculopapular rash after ~1 week  Koplik’s spots on oral mucosa  Rash starts from forehead, and spreads downwards  Resolution in same order over 3 days  Complications-  Viral or secondary bacterial pneumonia  Myocarditis, hepatitis, keratitis  Encephalomyelitis  Subacute sclerosing pan-encephalitis (SSPE)- rare, late
  • 4.
    Management  Dx-  Clinical Leukopenia  Measles virus/Ag in respiratory secretions/urine  Treatment- supportive  Prevention-  Passive immunization with immunoglobulin  Active immunization with vaccine
  • 5.
    Varicella-zoster  A DNAvirus  Man is only reservoir  Transmission- respiratory secretions-?  Highly contagious, >90% secondary attack rate  Incubation period- ~2 weeks  Causes-  Varicella/chicken-pox- primary infection- children  Zoster- reactivation- elderly/immunocompromised
  • 6.
    Clinical features  Varicella-lasts ~7 days  Fever, malaise  Rash- erythematous macules, papules, vesicles, scabs in various stages of evolution simultaneously  First on face & trunk, then spreads  Complication- secondary bacterial infection, pneumonia, hepatitis, ataxia, meningitis, myelitis  Herpes zoster- lasts ~7 days  Reactivation of virus from dorsal root ganglia  U/L dermatomal severe pain, followed by vesicular eruption  Complication- post-herpetic neuralgia, meningoencephalitis
  • 7.
    Management  Dx-  Clinical Tzanck smear- multinucleated giant-cell  Isolation of virus in tissue culture  Rising Ab titres  Rx-  Supportive  Acyclovir- oral/IV  Steroids & neuropathic analgesics for neuralgia  Prevention-  Passive immunoglobulins  Active vaccine
  • 8.
    Herpes simplex  Ads-DNA virus  HSV-1- oral, HSV-2- genital  Transmission- by direct contact, genital herpes considered a STD  Incubation period- ~1 week  Initial exposure- local viral replication  Through peripheral nerves, virus reaches ganglia  Replicates in ganglia & spreads centrifugally to skin via peripheral sensory nerves  Reactivation- with stress, trauma, immunosuppression
  • 9.
    Clinical features  Initialdisease more symptomatic than recurrences  Fever, malaise, myalgia; with painful vesicular eruption & regional LNE  Herpes labialis/orofacial/gingivostomatitis  Herpes genitalis  Herpetic whitlow- fingers  Herpetic keratoconjunctivitis  Herpes encephalitis
  • 10.
    Management  Dx-  Clinical DFA  Biopsy  IgG HSV test  Rx- topical/oral Acyclovir; reduce frequency, duration, severity; NOT CURATIVE  Prevention-  Barrier- condom  Prophylactic Acyclovir
  • 11.
    Rubella- German measles Caused by Rubella virus (RNA)  Incubation period- ~2-3 weeks  A benign febrile viral disease with LNE  Rash- discrete maculopapular rash, starts on forehead & face and spread down  Rash typically lasts for ~3 days  Prevention- live attenuated vaccine, specially to prevent congenital rubella
  • 12.
    Congenital rubella  Consistsof-  Cardiac malformation- PDA, VSD, PS  Eye lesions- clouded cornea, cataract, chorioretinitis  Microcephaly  Mental retardation  Deafness  Expanded rubella syndrome-  Purpura, HSmegaly, IUGR, pneumonitis, myocarditis  Late complications-  DM, subacute panencephalitis